An appraisal of the clinical use of lamotrigine under the special access scheme
- 1 July 1996
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 3 (3) , 239-242
- https://doi.org/10.1016/s0967-5868(96)90057-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Outcomes of Add‐on Treatment with Lamotrigine in Partial EpilepsyEpilepsia, 1993
- Interaction of lamotrigine with sodium valproateThe Lancet, 1993
- Lamotrigine for generalised epilepsiesThe Lancet, 1992
- LamotrigineThe Lancet, 1992
- A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizuresEpilepsy Research, 1990
- A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsyEpilepsy Research, 1990
- Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsyEpilepsy Research, 1989
- Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial SeizuresEpilepsia, 1989
- Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic DrugEpilepsia, 1986